Tara Mirzadegan

1.9k citations

25 papers · 1.5k indexed · h-index 16

Molecular Biology top 10%
Cellular and Molecular Neuroscience top 5%
Oncology top 10%
Immunology top 10%
Virology top 5%

Co-authors: Gil Benkö Krzysztof Palczewski Sławomir Filipek Klaus Klumpp Sunil Bhakta Mary A. Mulkins Kurt Jarnagin David S. Rotstein
Topics: Receptor Mechanisms and Signaling (9 papers)Neuropeptides and Animal Physiology (4 papers)Photoreceptor and optogenetics research (3 papers)
Cited by: Virology Cellular and Molecular Neuroscience Molecular Biology
Journals: Journal of Biological Chemistry Biochemistry Biochemical and Biophysical Research Communications
Partner nations: United States Switzerland Poland

In The Last Decade

Tara Mirzadegan

25 papers receiving 1.5k citations

Peers

Countries citing papers authored by Tara Mirzadegan

Since Specialization

Citations

This map shows the geographic impact of Tara Mirzadegan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tara Mirzadegan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tara Mirzadegan more than expected).

Fields of papers citing papers by Tara Mirzadegan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tara Mirzadegan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tara Mirzadegan. The network helps show where Tara Mirzadegan may publish in the future.

Co-authorship network of co-authors of Tara Mirzadegan

This figure shows the co-authorship network connecting the top 25 collaborators of Tara Mirzadegan. A scholar is included among the top collaborators of Tara Mirzadegan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tara Mirzadegan. Tara Mirzadegan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	D3R grand challenge 4: blind prediction of protein–ligand poses, affinity rankings, and relative binding free energies 2020 ·Journal of Computer-Aided Molecular Design ·conor parks,Zied Gaieb,Michael Chiu,Huanwang Yang,Chenghua Shao,W. Patrick Walters,Johanna M. Jansen,Georgia B. McGaughey,Richard A. Lewis,Scott D. Bembenek,Michael K. Ameriks,Tara Mirzadegan,S.K. Burley,Rommie E. Amaro,Michael K. Gilson	85
2	D3R Grand Challenge 3: blind prediction of protein–ligand poses and affinity rankings 2019 ·Journal of Computer-Aided Molecular Design ·Zied Gaieb,conor parks,Michael Chiu,Huanwang Yang,Chenghua Shao,W. Patrick Walters,Millard H. Lambert,Neysa Nevins,Scott D. Bembenek,Michael K. Ameriks,Tara Mirzadegan,S.K. Burley,Rommie E. Amaro,Michael K. Gilson	97
3	Computational chemistry at Janssen 2016 ·Journal of Computer-Aided Molecular Design ·Herman van Vlijmen,Renée L. DesJarlais,Tara Mirzadegan	14
4	A Single Amino Acid Difference between Mouse and Human 5-Lipoxygenase Activating Protein (FLAP) Explains the Speciation and Differential Pharmacology of Novel FLAP Inhibitors 2016 ·Journal of Biological Chemistry ·Jonathan M. Blevitt,Michael D. Hack,Krystal Herman,Leon Chang,John M. Keith,Tara Mirzadegan,Navin Rao,Alec D. Lebsack,Marcos E. Milla	12
5	Analysis of the Structural and Molecular Basis of Voltage-sensitive Sodium Channel Inhibition by the Spider Toxin Huwentoxin-IV (μ-TRTX-Hh2a) 2013 ·Journal of Biological Chemistry ·Natali A. Minassian,Alan C. Gibbs,Amy Y. Shih,Yi Liu,Robert A. Neff,Steven W. Sutton,Tara Mirzadegan,(unknown),(unknown),(unknown),(unknown),Michael J. Hunter,M.L. Flinspach,Alan D. Wickenden	61
6	Pharmacological Characterization of 1-(5-Chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic Acid (JNJ-42041935), a Potent and Selective Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor 2011 ·Molecular Pharmacology ·Terrance D. Barrett,(unknown),(unknown),Kimon C. Kanelakis,Xiaodong Wu,(unknown),Wen Yan,Andrew Young,(unknown),(unknown),Da‐Thao Tran,Hariharan Venkatesan,Mark D. Rosen,Hillary M. Peltier,(unknown),Michèle Rizzolio,Scott D. Bembenek,Tara Mirzadegan,Michael H. Rabinowitz,Nigel P. Shankley	65
7	Highly potent, non-basic 5-HT6 ligands. Site mutagenesis evidence for a second binding mode at 5-HT6 for antagonism 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),David B. Repke,(unknown),Keith A. M. Walker,Renée S. Martin,(unknown),Mariola Ilnicka,Simon W. Lee,Tara Mirzadegan	33
8	Molecular Interactions of CCR5 with Major Classes of Small-Molecule Anti-HIV CCR5 Antagonists 2007 ·Molecular Pharmacology ·Rama K. Kondru,Jun Zhang,Changhua Ji,Tara Mirzadegan,David S. Rotstein,Surya Sankuratri,Marianna Dioszegi	153
9	Substrate-dependent inhibition or stimulation of HIV RNase H activity by non-nucleoside reverse transcriptase inhibitors (NNRTIs) 2006 ·Biochemical and Biophysical Research Communications ·Julie Q. Hang,Yu Li,Yanli Yang,Nick Cammack,Tara Mirzadegan,Klaus Klumpp	42
10	Recent Progress in the Design of Small Molecule Inhibitors of HIV RNase H 2006 ·Current Pharmaceutical Design ·Klaus Klumpp,Tara Mirzadegan	64
11	Rational design of 6-methylsulfonylindoles as selective cyclooxygenase-2 inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey A. Campbell,(unknown),Chris A. Broka,Michelle F. Browner,(unknown),Tara Mirzadegan,C S Ramesha,(unknown),(unknown),(unknown),Armando G. Villaseñor,Keith A. M. Walker,Jinhai Wang,Mary Welch,Paul Weller	52
12	Lactams as EP₄Prostanoid Receptor Agonists. 3. Discovery ofN-Ethylbenzoic Acid 2-Pyrrolidinones as Subtype Selective Agents 2004 ·Journal of Medicinal Chemistry ·Todd R. Elworthy,(unknown),(unknown),Frances Chu,Jason Harris,R. Hendricks,(unknown),Woongki Kim,(unknown),Tara Mirzadegan,Calvin Yee,Keith A. M. Walker	28
13	Sequence Analyses of G-Protein-Coupled Receptors: Similarities to Rhodopsin 2003 ·Biochemistry ·Tara Mirzadegan,Gil Benkö,(unknown),Krzysztof Palczewski	11
14	CI-1017, a functionally M1-selective muscarinic agonist: design, synthesis, and preclinical pharmacology 2000 ·Pharmaceutica Acta Helvetiae ·Haile Tecle,Roy D. Schwarz,Stephen D. Barrett,Michael J. Callahan,Bradley W. Caprathe,Robert E. Davis,(unknown),Mark R. Emmerling,(unknown),Tara Mirzadegan,D.W. Moreland,(unknown),(unknown),C Raby,(unknown),K. Spiegel,A. Thomas,Juan C. Jaén	11
15	Identification of the Binding Site for a Novel Class of CCR2b Chemokine Receptor Antagonists 2000 ·Journal of Biological Chemistry ·Tara Mirzadegan,Frank Diehl,(unknown),Sunil Bhakta,(unknown),D J McCarley,Mary A. Mulkins,(unknown),Jean‐Marc Lapierre,John W. Dankwardt,David J. Morgans,Robert S. Wilhelm,Kurt Jarnagin	205
16	Identification of Residues in the Monocyte Chemotactic Protein-1 That Contact the MCP-1 Receptor, CCR2 1999 ·Biochemistry ·Stefan Hemmerich,Chad D. Paavola,A. Joseph Bloom,Sunil Bhakta,Richard Freedman,D. Grünberger,John L. Krstenansky,Simon J. Craddock Lee,(unknown),Mary A. Mulkins,(unknown),(unknown),Laura S. Mizoue,Tara Mirzadegan,(unknown),(unknown),Tracy M. Handel,Kurt Jarnagin	130
17	Mutations of aspartate 103 in the Hm2 receptor and alterations in receptor binding properties of muscarinic agonists 1995 ·Life Sciences ·Roy D. Schwarz,(unknown),Juan C. Jaén,Tara Mirzadegan,D.W. Moreland,Haile Tecle,Anthony J. Thomas	13
18	(±)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-methyl-5-aryl-2-penten-4-ynyl) oximes: Potent muscarinic agonists 1995 ·Bioorganic & Medicinal Chemistry Letters ·Haile Tecle,(unknown),Robert E. Davis,Tara Mirzadegan,D.W. Moreland,(unknown),A. Thomas,C Raby,(unknown),Mark R. Brann,Juan C. Jaén	4
19	Synthesis and Sar of bulky 1-azabicyclo[2.2.1]-3-one oximes as muscarinic receptor subtype selective agonists 1993 ·Life Sciences ·Haile Tecle,(unknown),Tara Mirzadegan,Walter H. Moos,D.W. Moreland,Michael R. Pavia,Roy D. Schwarz,Robert E. Davis	18
20	A rationale for the design and synthesis of m1 selective muscarinic agonists. 1992 ·Bioorganic & Medicinal Chemistry Letters ·Haile Tecle,Tara Mirzadegan,Walter H. Moos,D.W. Moreland,Michael R. Pavia,Roy D. Schwarz,Robert E. Davis	10

About Tara Mirzadegan

Tara Mirzadegan is a scholar working on Cellular and Molecular Neuroscience, Virology and Pharmacology, having authored 25 papers that have together received 1.5k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (9 papers), Neuropeptides and Animal Physiology (4 papers) and Photoreceptor and optogenetics research (3 papers). The work is most often cited by research in Virology (208 citations), Cellular and Molecular Neuroscience (301 citations) and Molecular Biology (933 citations). Tara Mirzadegan has collaborated with scholars based in United States, Switzerland and Poland. Frequent co-authors include Gil Benkö, Krzysztof Palczewski, Sławomir Filipek, Klaus Klumpp, Sunil Bhakta, Mary A. Mulkins, Kurt Jarnagin, David S. Rotstein, Jun Zhang and Rama K. Kondru. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact